Furthermore, GL disrupts the tumor microenvironment by inhibiting the autophagy-dependent release of HMGB1 from cancer-associated fibroblasts (CAFs), which in turn suppresses NF-κB-driven invasion and metastasis in non-small cell lung cancer models [109]. The gene discussed is HMGB1; the disease is non-small cell lung carcinoma.